We are live on ! Find out more
NICM

Neo Ivy Capital Management Portfolio holdings

AUM $379M
1-Year Est. Return 28.34%
This Fund
S&P 500
This Quarter Est. Return
+18.75%
1 Year Est. Return
+28.34%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$87.2M
AUM Growth
+$25.8M
Cap. Flow
+$18.4M
Cap. Flow %
21.14%
Top 10 Hldgs %
9.07%
Holding
666
New
217
Increased
117
Reduced
105
Closed
226

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$883K
2
LHX icon
L3Harris
LHX
+$877K
3
JNJ icon
Johnson & Johnson
JNJ
+$836K
4
INTC icon
Intel
INTC
+$803K
5
PRU icon
Prudential Financial
PRU
+$759K

Top Sells

Rank Stock Value
1
ETR icon
Entergy
ETR
+$563K
2
COST icon
Costco
COST
+$557K
3
CTAS icon
Cintas
CTAS
+$506K
4
TMO icon
Thermo Fisher Scientific
TMO
+$503K
5
ALK icon
Alaska Air
ALK
+$476K

Sector Composition

Rank Sector Weight
1 Technology 17.61%
2 Financials 17.3%
3 Industrials 15.25%
4 Healthcare 15.11%
5 Consumer Discretionary 9.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TJX icon
176
TJX Companies
TJX
$175B
$165K 0.19%
3,260
-8,472
-72% -$425K
PAYX icon
177
Paychex
PAYX
$43.1B
$164K 0.19%
+2,163
New +$150K
PG icon
178
Procter & Gamble
PG
$340B
$161K 0.18%
+1,349
New +$157K
WBD icon
179
Warner Bros
WBD
$67.4B
$161K 0.18%
7,634
-3,048
-29% -$65.8K
DPZ icon
180
Domino's
DPZ
$11.5B
$158K 0.18%
428
+375
+708% +$138K
ELV icon
181
Elevance Health
ELV
$86.2B
$157K 0.18%
598
-219
-27% -$58.4K
ATO icon
182
Atmos Energy
ATO
$28.4B
$155K 0.18%
+1,554
New +$157K
MCK icon
183
McKesson
MCK
$103B
$152K 0.17%
+992
New +$143K
AGIO icon
184
Agios Pharmaceuticals
AGIO
$1.95B
$149K 0.17%
+2,780
New +$129K
EQR icon
185
Equity Residential
EQR
$24.7B
$149K 0.17%
2,529
+1,731
+217% +$107K
FLG
186
Flagstar Bank National Association
FLG
$5.82B
$148K 0.17%
4,848
-2,165
-31% -$65.1K
CUBE icon
187
CubeSmart
CUBE
$9.23B
$147K 0.17%
5,454
-686
-11% -$18.1K
NFLX icon
188
Netflix
NFLX
$318B
$147K 0.17%
+3,230
New +$137K
PARA
189
DELISTED
Paramount Global Class B
PARA
$144K 0.17%
+6,161
New +$119K
KBR icon
190
KBR
KBR
$4.83B
$143K 0.16%
+6,345
New +$138K
SCI icon
191
Service Corp International
SCI
$11.4B
$143K 0.16%
3,689
-2,873
-44% -$110K
TSN icon
192
Tyson Foods
TSN
$20.1B
$143K 0.16%
+2,401
New +$146K
GMED icon
193
Globus Medical
GMED
$11.6B
$141K 0.16%
+2,960
New +$143K
LEA icon
194
Lear
LEA
$8.05B
$141K 0.16%
+1,297
New +$129K
RNR icon
195
RenaissanceRe
RNR
$13.2B
$141K 0.16%
+825
New +$135K
HDS
196
DELISTED
HD Supply Holdings, Inc.
HDS
$139K 0.16%
4,022
-9,845
-71% -$305K
GE icon
197
GE Aerospace
GE
$380B
$138K 0.16%
+4,039
New +$136K
MC icon
198
Moelis & Co
MC
$4.72B
$137K 0.16%
+4,399
New +$138K
TGNA
199
DELISTED
TEGNA Inc
TGNA
$137K 0.16%
12,332
+6,654
+117% +$74K
VLO icon
200
Valero Energy
VLO
$90.7B
$137K 0.16%
2,324
-1,737
-43% -$104K
6 7
8
9 10

Similar funds

KFS
Kurt F. Somerville $379M AUM 19.42% 1-Year Est. Return
MC
Muhlenkamp & Co Wexford, Pennsylvania $380M AUM 43.74% 1-Year Est. Return
ACA
Anchorage Capital Advisors New York $378M AUM 13.47% 1-Year Est. Return
AFCM
Alta Fox Capital Management Fort Worth, Texas $378M AUM 59.19% 1-Year Est. Return
DAL
Delta Air Lines Atlanta, Georgia $378M AUM 12.68% 1-Year Est. Return
SFWC
Strategic Family Wealth Counselors Fairfield, New Jersey $381M AUM 21.36% 1-Year Est. Return
WAM
Wakefield Asset Management Englewood, Colorado $377M AUM 38.72% 1-Year Est. Return
FP
Fivespan Partners San Francisco, California $377M AUM

Neo Ivy Capital Management's Q2 2020 Portfolio in Review

As of Q2 2020, Neo Ivy Capital Management held 666 positions worth $87.2M, up 42% from $61.4M the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.

Neo Ivy Capital Management deployed $18.4M of net new capital in Q2 2020, opening 217 new positions and adding to 117 existing holdings. Its largest new stake was Pfizer: 26,000 shares worth $807K.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Cintas, an estimated $506K trimmed.

  • Neo Ivy Capital Management's largest Q2 2020 buy was Pfizer: 26,000 shares worth $807K.
  • Neo Ivy Capital Management added most to CME Group in Q2 2020, an estimated $750K increase.
  • Neo Ivy Capital Management's biggest Q2 2020 reduction was Cintas, cutting an estimated $506K.
  • Neo Ivy Capital Management fully exited Entergy in Q2 2020, selling an estimated $563K.
  • Neo Ivy Capital Management's ten largest holdings make up 9.1% of its $87.2M portfolio in Q2 2020.
  • Neo Ivy Capital Management opened 217 new positions and closed 226 in Q2 2020.
  • Neo Ivy Capital Management's portfolio value rose 42% quarter-over-quarter to $87.2M.

Based on Neo Ivy Capital Management's 13F filing for Q2 2020, filed 17 Aug 2020.